Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab

Heidi Bai; Emi M Murase; Alyssa G Ashbaugh; Nina B Botto; Jenny E Murase

doi:10.1016/j.jaad.2022.03.047

Diagnostic testing of eczematous dermatitis with incomplete response to dupilumab

J Am Acad Dermatol. 2022 Sep;87(3):692-695. doi: 10.1016/j.jaad.2022.03.047. Epub 2022 Mar 31.

Authors

Heidi Bai¹, Emi M Murase², Alyssa G Ashbaugh³, Nina B Botto³, Jenny E Murase⁴

Affiliations

¹ University of Rochester School of Medicine & Dentistry, Rochester, New York.
² San Francisco Dermatology Society, San Francisco, California.
³ Department of Dermatology, University of California, San Francisco, California.
⁴ Department of Dermatology, University of California, San Francisco, California; Department of Dermatology, Palo Alto Foundation Medical Group, Mountain View, California. Electronic address: [email protected].

PMID: 35367296
DOI: 10.1016/j.jaad.2022.03.047

No abstract available

Keywords: allergic contact dermatitis; atopic dermatitis; cutaneous lupus; dermatology; dupilumab; patch testing; photodermatitis; polymorphous light eruption.

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use
Diagnostic Techniques and Procedures
Eczema* / diagnosis
Eczema* / drug therapy
Humans

Substances

Antibodies, Monoclonal, Humanized
dupilumab